Short therapy in a septic arthritis of the neonatal hip

Antonio Gatto1, Ilaria Lazzareschi1, Roberta Onesimo1

  • 1Institute of Pediatrics, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Pediatric Reports
|October 8, 2019
PubMed

Insights

Septic arthritis (SA) in neonates is challenging to diagnose but can be effectively treated. This case study shows a good outcome for neonatal hip arthritis using a short, 2-week antibiotic course.

Area of Science:

  • Pediatric Infectious Diseases
  • Neonatal Care
  • Orthopedic Surgery

Background:

  • Septic arthritis (SA) is a severe joint infection causing significant morbidity and potential long-term joint damage.
  • Diagnosis of SA in neonates is difficult due to subtle clinical signs.
  • Current treatment guidelines for pediatric SA involve prolonged antibiotic therapy and surgery, with no consensus on antibiotic duration.

Purpose of the Study:

  • To report a case of neonatal hip arthritis with a favorable outcome.
  • To evaluate the efficacy of a short antibiotic course in treating neonatal septic arthritis.

Main Methods:

  • Case report of a neonate diagnosed with hip septic arthritis.
  • Treatment involved a 2-week course of antibiotics.
  • Clinical outcome and joint health were monitored post-treatment.

Main Results:

  • The neonate with septic arthritis of the hip achieved a good outcome.
  • A short, 2-week antibiotic regimen was sufficient for successful treatment.
  • This suggests that shorter antibiotic durations may be viable in select neonatal cases.

Conclusions:

  • Neonatal septic arthritis, even in challenging joints like the hip, can have a good prognosis with prompt treatment.
  • A 2-week antibiotic course may be adequate for treating neonatal hip septic arthritis, challenging the need for prolonged therapy.
  • Further research is warranted to establish evidence-based guidelines for antibiotic duration in neonatal SA.